Victoria Ly, MD, MPH, outlines one method of tackling vision screening follow-up rate disparities among children in Arkansas.
School districts across the state may be able to partner with their local ophthalmologists or optometrists, said Victoria Ly, MD, MPH, an intern resident physician at University of Texas Southwestern Medical Center in ophthalmology.
Transcript
What can be done to increase vision screening follow-up rates among Arkansas children?
To address those disparities and increase follow-up rates, I would focus more on pursuing tactics that improve accessibility to the eye care. I, as a medical student, was volunteering at this free school physical day at the Children's Hospital. And it pretty much was a couple of days through the week where busloads of students from across the Tri-County area would come to the hospital and we volunteered and did their school sports physicals for free. I think we could kind of model something like that, where across the state school districts could partner with their local optometrists or local ophthalmologists and have the busloads of kids that had failed their school vision screenings come to the clinic, get their assessment done. Then they could bring that report back to their parents. I think that would help mitigate some issues such as financial and logistical barriers that parents might face when taking their kids to the doctor. For instance, I know in Arkansas, there are a lot of medically underserved areas. So transporting your child from home to the next eye doctor, maybe 40 or 60 miles away, can be an issue especially, if you have a lot of kids at home that you have to be taken care of as well. So that could be something.
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
Designing Care for the Underserved Creates Higher-Value Health Solutions
January 12th 2025In the second half of our interview with Brita Roy, MD, MPH, MHS, NYU Grossman School of Medicine, she discusses effective engagement of minoritized populations in discussion of medical mistrust.
Read More
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More